Page last updated: 2024-08-18

quinuclidines and Lung Diseases

quinuclidines has been researched along with Lung Diseases in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Li, HJ; Li, WO; Liang, XQ; Wang, DX; Wang, T; Yan, T; Zhu, SN	1
Barrett, VJ; Buckley, PT; Burman, M; DeHaas, CJ; Foley, JJ; Hay, DW; Kotzer, CJ; Lainé, DI; Luttmann, MA; Palovich, MR; Rumsey, WL; Salmon, M; Sarau, HM; Schmidt, DB; Slack, RJ; Webb, EF	1
Wang, D; Yan, T	1
Bhatia, M; Hegde, A; Moochhala, SM; Zhang, H	1

Trials

2 trial(s) available for quinuclidines and Lung Diseases

Article	Year
Prophylactic penehyclidine inhalation for prevention of postoperative pulmonary complications in high-risk patients: study protocol of a randomized controlled trial. Trials, 2017, Nov-28, Volume: 18, Issue:1 Topics: Administration, Inhalation; Aged; Aged, 80 and over; Cause of Death; China; Clinical Protocols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Length of Stay; Lung Diseases; Male; Middle Aged; Muscarinic Antagonists; Postoperative Complications; Prospective Studies; Quinuclidines; Research Design; Risk Factors; Time Factors; Treatment Outcome	2017
[Effects of penehyclidine inhalation on postoperative pulmonary complications of elderly patients after long-duration surgery]. Zhonghua yi xue za zhi, 2014, Jan-14, Volume: 94, Issue:2 Topics: Administration, Inhalation; Aged; Aged, 80 and over; Anesthesia; Bronchial Spasm; Double-Blind Method; Female; Humans; Intubation, Intratracheal; Lung Diseases; Male; Postoperative Complications; Prospective Studies; Quinuclidines	2014

Article

Year

Prophylactic penehyclidine inhalation for prevention of postoperative pulmonary complications in high-risk patients: study protocol of a randomized controlled trial.

Trials, 2017, Nov-28, Volume: 18, Issue:1

Topics: Administration, Inhalation; Aged; Aged, 80 and over; Cause of Death; China; Clinical Protocols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Length of Stay; Lung Diseases; Male; Middle Aged; Muscarinic Antagonists; Postoperative Complications; Prospective Studies; Quinuclidines; Research Design; Risk Factors; Time Factors; Treatment Outcome

2017

[Effects of penehyclidine inhalation on postoperative pulmonary complications of elderly patients after long-duration surgery].

Zhonghua yi xue za zhi, 2014, Jan-14, Volume: 94, Issue:2

Topics: Administration, Inhalation; Aged; Aged, 80 and over; Anesthesia; Bronchial Spasm; Double-Blind Method; Female; Humans; Intubation, Intratracheal; Lung Diseases; Male; Postoperative Complications; Prospective Studies; Quinuclidines

2014

Other Studies

2 other study(ies) available for quinuclidines and Lung Diseases

Article	Year
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 345, Issue:2 Topics: Administration, Inhalation; Animals; Calcium; Carbachol; CHO Cells; Cholinergic Antagonists; Cricetinae; Cricetulus; Guinea Pigs; Kinetics; Lung; Lung Diseases; Mice; Mice, Inbred BALB C; Muscarinic Agonists; Muscarinic Antagonists; Plethysmography; Quinuclidines; Receptor, Muscarinic M3; Receptors, Muscarinic; Scopolamine Derivatives; Tiotropium Bromide	2013
Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis. Journal of leukocyte biology, 2007, Volume: 82, Issue:3 Topics: Animals; Cecum; Chemokines; Cytokines; Enzyme-Linked Immunosorbent Assay; Lung; Lung Diseases; Lung Injury; Male; Mice; Neurokinin-1 Receptor Antagonists; Neutrophils; Peroxidase; Piperidines; Protein Precursors; Quinuclidines; Receptors, Neurokinin-1; Sepsis; Stereoisomerism; Tachykinins	2007

Article

Year

Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.

The Journal of pharmacology and experimental therapeutics, 2013, Volume: 345, Issue:2

Topics: Administration, Inhalation; Animals; Calcium; Carbachol; CHO Cells; Cholinergic Antagonists; Cricetinae; Cricetulus; Guinea Pigs; Kinetics; Lung; Lung Diseases; Mice; Mice, Inbred BALB C; Muscarinic Agonists; Muscarinic Antagonists; Plethysmography; Quinuclidines; Receptor, Muscarinic M3; Receptors, Muscarinic; Scopolamine Derivatives; Tiotropium Bromide

2013

Neurokinin-1 receptor antagonist treatment protects mice against lung injury in polymicrobial sepsis.

Journal of leukocyte biology, 2007, Volume: 82, Issue:3

Topics: Animals; Cecum; Chemokines; Cytokines; Enzyme-Linked Immunosorbent Assay; Lung; Lung Diseases; Lung Injury; Male; Mice; Neurokinin-1 Receptor Antagonists; Neutrophils; Peroxidase; Piperidines; Protein Precursors; Quinuclidines; Receptors, Neurokinin-1; Sepsis; Stereoisomerism; Tachykinins

2007